Another direct inhibitor of PP2A, LB102, is a lipid-soluble homolog of LB100 that has antitumor efficacy demonstrated by the chemosensitizing of GBM cells to DNA-alkylating agents [10,94]. Here, PTPA is linked to glioblastoma.